Thomas H. Glocer

The record of Thomas H. Glocer is modest in open-market trades: 3 sales, EUR 1,262,194 in total, a median of EUR 356,874, and no purchase. The highest, EUR 663,100 at Merck & Co., Inc., is dated February 4, 2019. Another, EUR 242,219, is dated November 8, 2017 at Merck; the third, EUR 356,874, is at Morgan Stanley on May 3, 2023.

The 36 filings come from Morgan Stanley (31) and Merck & Co., Inc. (5), always as Director. Grants make up most of them, with 30 filings, ahead of 3 option exercises.

The pace is low and stable: 3 to 6 filings a year between 2016 and 2025, with a high of 6 in 2019 and 5 in 2017. The last is published on December 2, 2025 and is the only one in the last twelve months, with no purchase or sale. Filings come out a median of 2 days after the trade.

The count of trades by Glocer within 30 days of colleagues is 1, 1 and 1. All on the same side. The colleagues, in the same order: Kenneth C. Frazier (Merck & Co., Inc.), Leslie A. Brun (Merck & Co., Inc.) and Raja Akram (Morgan Stanley).